Orion Oyj: Orion s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy
Orion
A novel treatment, a digital therapeutics software solution for Chronic Pain (DTxP)
,
passive (placebo)
control and standard care interventions for fear of movement, patient clinical global impression of change (PGIC) and quality of life in adult patien
t V
SP 2021 Virtual World Congress O
n Pain
.
Results from the VIRPI study in patients with CLBP showed that TSK score (Tampa Scale for Kinesiophobia assessing fear of movement) was significantly reduced at the end-of-intervention (EOI) for DTxP. Primary analysis for the difference between DTxP and passive control at EOI was statistically significant: -4.7 points (-9.4 to -0.1, p=0.046) and increased when compared to standard care -6.1 (-10.9 to -1.3, p=0.014). Patient clinical global impression of change (PGIC), which reflects a patient s belief about the efficacy of the treatment, and their qua